Amin Farhoomand News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Through the Ride Health platform, a study coordinator can request rides on behalf of participants. (Ride Health)
Access to private transportation, or lack thereof, has long been a barrier to participation in clinical trials. And COVID-19 isn’t making things easier, with public health guidelines discouraging the use of public transport and ride-hailing services setting up policies against passengers with COVID-19 symptoms.
So, how are institutions running COVID-19 trials getting patients in for site visits? New York-based Ride Health is on the job.
The company is partnering with ACTIV-2, a study backed by the National Institutes of Health (NIH) testing treatments for COVID-19, and the NIH-founded COVID-19 Prevention Trials Network (CoVPN), the “harmonizer” network for the five vaccine trials backed by Operation Warp Speed. It will provide transportation to and from study sites for participants through its network of COVID-19-equipped providers. That means ....

Puerto Rico , South Dakota , United States , Judith Currier , Eli Lilly , Imran Cronk , Amin Farhoomand , Centers For Disease , National Institutes Of Health , Nstride Health , Clinical Trials Group , Amin Farhoomand Ride Health , Imran Cronk Ride Health , Prevention Trials Network Co , New York Based Ride Health , National Institutes , Trials Network , Operation Warp , Disease Control , Trials Group , Corona Virus , National Institutes Of Health Nih , Covid 19 , Clinical Research , ப்வெர்டோ ரிக்கோ , தெற்கு டகோட்டா ,